Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
News Corp Q3 FY2026 Earnings Call - AI Licensing Deals and Core Pillars Drive 18% EBITDA Growth
News Corp reported a strong third quarter for fiscal 2026, with total revenue rising 9% to $2.2 billion and total segment EBITDA surging 18% to $343 million. The results were driven by double-digit pr...
- Total segment EBITDA grew 18% to $343 million, marking the 12th consecutive quarter of year-over-year growth and expanding margins from 14.4% to 15.7%.
- Dow Jones segment EBITDA rose 11% to $147 million, driven by a 19% surge in Risk & Compliance revenue and 12% growth in Dow Jones Energy.
- Digital Real Estate Services segment EBITDA jumped 25% to $155 million, with Realtor.com revenue up 10% despite high mortgage rates and REA revenue growing 20%.
- +7 more takeaways
DXC Technology Q4 FY2026 Earnings Call - AI-Driven Margin Expansion Stalls Amid Discretionary Spending Weakness
DXC Technology reported a fourth quarter that highlighted a stark duality: profitability metrics beat guidance while top-line execution stumbled. Adjusted EBIT margin of 7.6% and free cash flow of $71...
- Revenue missed guidance by $75 million, reflecting a 6.6% year-over-year decline to $3.1 billion, driven by weakness in discretionary project-based services across GIS and CES.
- Adjusted EBIT margin of 7.6% beat guidance, up 30 basis points year-over-year, supported by spending management and a one-time non-recurring item.
- Free cash flow for the full fiscal year reached $713 million, ahead of expectations, and was bolstered by lower cash taxes and reduced capital expenditures.
- +7 more takeaways
Sweetgreen, Inc. Q1 2026 Earnings Call - Wraps Launch Signals Early Turnaround in Pressured Quarter
Sweetgreen reported a difficult first quarter for fiscal 2026, with comparable sales down 12.8% due to weather headwinds, a tough prior-year comparison to the Ripple Fries launch, and ongoing operatio...
- Comparable sales declined 12.8% in Q1 2026, driven by an 11.2% drop in traffic and a 2.3% decline in mix, partially offset by 70 basis points of menu pricing.
- Revenue totaled $161.5 million, while restaurant-level margin contracted to 10% from 17.9% year-over-year, reflecting higher ingredient usage and sales deleverage.
- Adjusted EBITDA was a loss of $8.1 million, compared to a gain of $285,000 in the prior year, primarily due to lower restaurant-level profitability.
- +7 more takeaways
MercadoLibre Q1 2026 Earnings Call - 49% Revenue Growth Driven by Aggressive Ecosystem Investments
MercadoLibre delivered its strongest revenue growth in over three years, with top-line expansion accelerating to 49% year-over-year in Q1 2026. The company is deliberately compressing near-term margin...
- Revenue grew 49% year-over-year, marking the fastest growth rate since Q2 2022 and underscoring the compounding effect of prior strategic investments.
- Brazil commerce delivered standout results with GMV up 38% and items sold accelerating 56%, driven by the sustained impact of lowering the free shipping threshold.
- Unit economics improved sharply as cost per shipment fell 17% year-over-year, demonstrating that higher demand is actively driving down logistics costs.
- +7 more takeaways
Toast Q1 2026 Earnings Call - Agentic AI Strategy Drives Margin Expansion and New TAM Growth
Toast delivered a strong start to 2026, with recurring gross profit up 27% and GAAP operating margins hitting 21%. The company is executing its three-part strategy: evolving from a software platform t...
- Recurring gross profit streams grew 27% year-over-year, outpacing top-line growth and signaling strong pricing power and product attach.
- GAAP operating income margin expanded to 21%, marking a structural shift toward sustained profitability as the company scales.
- Toast is pivoting from a software platform to an agentic AI model, launching Toast IQ Grow with a marketing agent that has driven an 8% sales lift for early adopters.
- +9 more takeaways
TSS, Inc. Q1 2026 Earnings Call - Systems Integration Margins Expand as AI Demand Outpaces Supply
TSS, Inc. delivered a Q1 2026 where total revenue fell 44% year-over-year to $55.3 million, primarily because a massive drop in low-margin procurement services ($40 million, down 56%) offset an 88% su...
- Total revenue fell 44% year-over-year to $55.3 million, driven by a 56% drop in procurement services from $90.2 million to $40 million.
- Systems integration revenue surged 88% year-over-year to $14.1 million, representing a structural shift toward higher-margin, recurring AI infrastructure work.
- Gross margin expanded significantly from 9.3% in Q1 2025 to 15.9% in Q1 2026, fueled by the favorable shift in revenue mix toward systems integration.
- +7 more takeaways
Stoke Therapeutics Q1 2026 Earnings Call - Zorevunersen 4-Year Data Shows Durability, EMPEROR Enrollment Nears Completion
Stoke Therapeutics reported robust four-year longitudinal data for zorevunersen, its antisense oligonucleotide targeting the root cause of Dravet syndrome. The open-label extension study demonstrated ...
- Zorevunersen 4-Year Data: Open-label extension data through month 48 show median major motor seizure frequency reductions of 59-91% and statistically significant improvements in five Vineland-3 cognitive and behavioral subdomains, supporting disease-modifying claims.
- EMPEROR Study Progress: Phase III trial has randomized 130 of ~150 planned patients; U.S., U.K., and Japan enrollment is closing in June, with a data readout targeted for mid-2027.
- Financial Position: The company ended Q1 2026 with $411 million in cash and marketable securities, providing runway through the phase III readout and potential U.S. launch in late 2027 or early 2028.
- +7 more takeaways
The Joint Corporation Q1 2026 Earnings Call - Refranchising Nears Completion as Pure-Play Franchisor Model Takes Shape
The Joint Corporation delivered a Q1 2026 report that underscored a structural pivot from a company-owned clinic operator to a capital-light franchisor. Revenue from continuing operations rose 13% to ...
- Revenue from continuing operations grew 13% year-over-year to $14.8 million, reflecting early benefits of transitioning clinics to the franchise model.
- Adjusted EBITDA from continuing operations surged to $2.2 million from $46,000 in Q1 2025, demonstrating significant operating leverage as the company shifts toward royalty and fee-based revenue.
- The company is on track to reduce its corporate clinic count from 135 to just three through pending asset purchase agreements in Southern California and other regions, effectively completing the Joint 2.0 transformation.
- +7 more takeaways
Maravai LifeSciences Q1 2026 Earnings Call - EBITDA Guidance Raised Sharply on Margin Expansion and Strong Base Demand
Maravai LifeSciences delivered a robust Q1 2026, posting $65.8 million in revenue, up 41% year-over-year, with base business growth of 10% after excluding non-recurring COVID CleanCap revenue. The qua...
- Total Q1 revenue reached $65.8 million, representing 41% year-over-year growth, with base business growth of 10% after excluding non-recurring COVID CleanCap revenue.
- Adjusted EBITDA surged to $20.3 million, exceeding expectations and improving over $30 million year-over-year, driven by favorable product mix and cost discipline.
- Management substantially raised full-year adjusted EBITDA guidance to $30–32 million, up $61–63 million year-over-year, reflecting improved profitability flow-through.
- +12 more takeaways
PRA Group Q1 2026 Earnings Call - Legal & Digital Channels Drive 11% Cash Collection Growth
PRA Group delivered a solid start to 2026 with cash collections up 11% year-over-year, fueled by accelerating legal and digital channels in the U.S. and broad-based strength in Europe. The company mai...
- Cash collections grew 11% year-over-year to $552 million, with U.S. collections up 11% and Europe up 15%, exceeding guidance by 3% globally.
- Legal channel expansion drove U.S. growth, with legal collections rising 27% to $141 million and now representing 53% of U.S. core cash collections, up from 46% in Q1 2025.
- Adjusted EBITDA for the trailing twelve months rose 14% to $1.3 billion, outpacing cash collection growth and highlighting improving operating leverage despite a $15 million increase in legal collection costs.
- +7 more takeaways